Impact of galacto-oligosaccharides on the gut microbiota composition and metabolic activity upon antibiotic treatment during in vitro fermentation

FEMS Microbiology Ecology

Volumn 87, Issue 1, 2014, Pages 41-51

  Ladirat, Stephanie E ^a   Schuren, Frank H J ^b   Schoterman, Margriet H C ^c   Nauta, Arjen ^c   Gruppen, Harry ^a   Schols, Henk A ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

^c FRIESLANDCAMPINA   (Netherlands)

Author keywords

Amoxicillin; Ciprofloxacin; Clindamycin; Doxycycline; Phylogenetic microarray; Prebiotic

Indexed keywords

ANTIBIOTICS; BACTERIUM; BIODEGRADATION; CARBOHYDRATE; COMMUNITY COMPOSITION; FERMENTATION; GROWTH RATE; METABOLISM; MICROBIAL COMMUNITY; ORGANIC ACID; PHYLOGENETICS;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM; LACTOBACILLUS;

AMOXICILLIN; ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; GALACTOSE; OLIGOSACCHARIDE; PREBIOTIC AGENT;

ARTICLE; BACTERIUM; BIFIDOBACTERIUM; DRUG EFFECT; FERMENTATION; GASTROINTESTINAL TRACT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; LACTOBACILLUS; METABOLISM; MICROBIOLOGY; MICROFLORA; PHYLOGENETIC MICROARRAY;

AMOXICILLIN; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; PHYLOGENETIC MICROARRAY; PREBIOTIC;

ANTI-BACTERIAL AGENTS; BACTERIA; BIFIDOBACTERIUM; FERMENTATION; GALACTOSE; GASTROINTESTINAL TRACT; HUMANS; LACTOBACILLUS; MICROBIOTA; OLIGOSACCHARIDES; PREBIOTICS;

EID: 84891494259     PISSN: 01686496     EISSN: 15746941     Source Type: Journal    
DOI: 10.1111/1574-6941.12187     Document Type: Article

References (29)

1. Barboza M, Sela DA, Pirim C et al. (2009) Glycoprofiling bifidobacterial consumption of galacto-oligosaccharides by mass spectrometry reveals strain-specific, preferential consumption of glycans. Appl Environ Microbiol 75: 7319-7325.
2. Belenguer A, Duncan SH, Calder AG, Holtrop G, Louis P, Lobley GE & Flint HJ (2006) Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 72: 3593-3599.
3. Blaut M & Clavel T (2007) Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 137: 751S-755S.
4. Brötz-Oesterhelt H & Brunner NA (2008) How many modes of action should an antibiotic have? Curr Opin Pharmacol 8: 564-573.
5. Coulier L, Timmermans J, Richard B et al. (2009) In-depth characterization of prebiotic galacto-oligosaccharides by a combination of analytical techniques. J Agric Food Chem 57: 8488-8495.
6. ECEC surveillance report (2010) Available at: http://ecdc.europa.eu/en/publications/Publications/antimicrobial-antibiotic-consumption-ESAC-report-2010-data.pdf
7. EUCAST breakpoints Available at: http://www.eucast.org/eucast_disk_diffusion_test/ breakpoints/
8. Fooks LJ & Gibson GR (2003) Mixed culture fermentation studies on the effects of synbiotics on the human intestinal pathogens Campylobacter jejuni and Escherichia coli. Anaerobe 9: 231-242.
9. Gibson GR, Probert HM, Van Loo J, Rastall RA & Roberfroid MB (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17: 259-275.
10. Gibson GR, McCartney AL & Rastall RA (2005) Prebiotics and resistance to gastrointestinal infections. Br J Nutr 93: S31-S34.
11. Guarner F & Malagelada JR (2003) Gut flora in health and disease. Lancet 361: 512-519.
12. Hernot DC, Boileau TW, Bauer LL, Middelbos IS, Murphy MR, Swanson KS & Fahey GC Jr (2009) In vitro fermentation profiles, gas production rates, and microbiota modulation as affected by certain fructans, galactooligosaccharides, and polydextrose. J Agric Food Chem 57: 1354-1361.
13. Hopkins MJ & Macfarlane GT (2003) Non-digestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in-vitro. Appl Environ Microbiol 69: 1920-1927.
14. Ladirat SE, Schols HA, Nauta A et al. (2013) High-throughput analysis of the impact of antibiotics on the human intestinal microbiota composition. J Microbiol Methods 92: 387-397.
15. Lewis S, Burmeister S & Brazier J (2005a) Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study. Clin Gastroenterol Hepatol 3: 442-448.
16. Lewis S, Burmeister S, Cohen S, Brazier J & Awasthi A (2005b) Failure of dietary oligofructose to prevent antibiotic-associated diarrhoea. Aliment Pharmacol Ther 21: 469-477.
17. Macfarlane GT & Macfarlane LE (2009) Acquisition, evolution and maintenance of the normal gut microbiota. Dig Dis 27: 90-98.
18. Macfarlane S, Macfarlane GT & Cummings JH (2006) Review article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther 24: 701-714.
19. Macfarlane GT, Steed H & Macfarlane S (2008) Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol 104: 305-344.
20. Masco L, Van Hoorde K, De Brandt E, Swings J & Huys G (2006) Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products. J Antimicrob Chemother 58: 85-94.
21. McFarland LV (2008) Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol 3: 563-578.
22. Orrhage K, Sjöstedtb S & Nord CE (2000) Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil. J Antimicrob Chemother 46: 603-611.
23. Preidis GA & Versalovic J (2009) Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 136: 2015-2031.
24. Saulnier DM, Kolida S & Gibson GR (2009) Microbiology of the human intestinal tract and approaches for its dietary modulation. Curr Pharm Des 15: 1403-1414.
25. Sonnenburg JL, Chen CTL & Gordon JI (2006) Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol 4: 2213-2226.
26. Sullivan A (2001) Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 1: 101-114.
27. van den Broek LAM, Hinz SWA, Beldman G, Vincken J-P & Voragen AGJ (2008) Bifidobacterium carbohydrases-their role in breakdown and synthesis of (potential) prebiotics. Mol Nutr Food Res 52: 146-163.
28. Willing BP, Russell SL & Finlay BB (2011) Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol 9: 233-243.
29. Yap IKS, Li JV, Saric J et al. (2008) Metabonomic and microbiological analysis of the dynamic effect of vancomycin-lnduced gut microbiota modification in the mouse. J Proteome Res 7: 3718-3728.